Laurion Capital Management logo

Laurion Capital Management

North America, New York, United States, New York

Description

Laurion Capital Management is a private hedge fund sponsor

Investor Profile

Laurion Capital Management has made 25 investments, with 1 in the past 12 months and 4% as lead.

Stage Focus

  • Post Ipo Equity (24%)
  • Series B (20%)
  • Series D (16%)
  • Series Unknown (12%)
  • Series A (12%)
  • Series E (8%)
  • Pre Seed (4%)
  • Series C (4%)

Country Focus

  • United States (76%)
  • United Kingdom (16%)
  • China (4%)
  • France (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Software
  • Therapeutics
  • Medical
  • Artificial Intelligence (Ai)
  • Life Science
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Laurion Capital Management frequently co-invest with?

Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 4
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 3
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 4
Citi
North America, New York, United States, New York
Co-Investments: 3
Mubadala Capital Ventures
North America, California, United States, San Francisco
Co-Investments: 3
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 6
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 5
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 3
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 3
Invus
North America, New York, United States, New York
Co-Investments: 4

Which angels does Laurion Capital Management often collaborate with?

AL
North America, District of Columbia, United States, Washington
Shared Deals: 1
DS
North America, Massachusetts, United States, Boston
Shared Deals: 1
CG
North America, California, United States, Los Angeles
Shared Deals: 1
CM
North America, California, United States, San Francisco
Shared Deals: 1
NR
North America, California, United States, San Francisco
Shared Deals: 1
AM
North America, California, United States, San Francisco
Shared Deals: 1
HS
North America, California, United States, Redwood City
Shared Deals: 1
RN
North America, New York, United States, New York
Shared Deals: 1
IA
North America, California, United States, San Francisco
Shared Deals: 1
AP
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Laurion Capital Management?

Aardvark Therapeutics

San Diego, California, United States

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series CMay 9, 2024
Amount Raised: $85,000,000
Leap Therapeutics

Cambridge, Massachusetts, United States

Leap Therapeutics is a clinical-stage biopharmaceutical company for development of targeted and immuno-oncology therapeutics.

BiotechnologyLife ScienceMedicalOncology
Post Ipo EquityApr 10, 2024
Amount Raised: $40,000,000
Pyxis Oncology

Boston, Massachusetts, United States

Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.

BiotechnologyHealth CareOncologyPharmaceutical
Post Ipo EquityFeb 27, 2024
Amount Raised: $50,000,000
Pepgen

Oxford, Oxfordshire, United Kingdom

PepGen is empowering nucleic acid therapeutics to go the distance.

BiotechnologyClinical TrialsMedical
Post Ipo EquityFeb 7, 2024
Amount Raised: $80,100,000
COMPASS Pathways

Altrincham, Cheshire, United Kingdom

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

BiotechnologyHealth CareLife ScienceMental HealthPersonal HealthWellness
Post Ipo EquityAug 16, 2023
Amount Raised: $125,000,000
MerQube

San Francisco, California, United States

MerQube is a financial indexing tool offering design and computation solutions for rule-based investment and passive strategies.

Big DataCloud InfrastructureFinancial ServicesFinTechInformation Services
Series BJul 13, 2023
Amount Raised: $22,000,000
Axoni

New York, New York, United States

Axoni is a real-time data replication technology company serving the world’s largest financial institutions.

Financial ServicesFinTechSoftware
Series UnknownApr 26, 2023
Amount Raised: $20,000,000
Opensee

Paris, Ile-de-France, France

Opensee helps financial institutions’ business users interactively harness 100% of their vast quantities of data

AnalyticsBig DataFinancial ServicesFinTechSoftware
Series ADec 15, 2022
Amount Raised: $11,702,626
Recursion Pharmaceuticals

Salt Lake City, Utah, United States

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics
Post Ipo EquityOct 25, 2022
Amount Raised: $150,000,000
Solid Biosciences

Marlborough, Massachusetts, United States

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

BiotechnologyGeneticsHealth CareMedical
Post Ipo EquitySep 30, 2022
Amount Raised: $75,000,000